Canada Markets close in 4 hrs 6 mins

EyeGate Pharmaceuticals, Inc. (EYEG)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9500-0.0300 (-1.52%)
As of 03:00PM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.12
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 38.1800
52 Week Low 31.2827
50-Day Moving Average 31.8592
200-Day Moving Average 33.4704

Share Statistics

Avg Vol (3 month) 31.57M
Avg Vol (10 day) 3579.18k
Shares Outstanding 57.1M
Implied Shares Outstanding 6N/A
Float 89.85M
% Held by Insiders 112.18%
% Held by Institutions 124.20%
Shares Short (Aug. 12, 2021) 454.54k
Short Ratio (Aug. 12, 2021) 40.02
Short % of Float (Aug. 12, 2021) 40.60%
Short % of Shares Outstanding (Aug. 12, 2021) 40.43%
Shares Short (prior month Jul. 14, 2021) 471.08k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug. 29, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Aug. 29, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-77,807.79%

Management Effectiveness

Return on Assets (ttm)-40.35%
Return on Equity (ttm)-103.80%

Income Statement

Revenue (ttm)12.06k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-3.55M
Net Income Avi to Common (ttm)-9.47M
Diluted EPS (ttm)-1.7680
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.66M
Total Cash Per Share (mrq)0.29
Total Debt (mrq)308.01k
Total Debt/Equity (mrq)2.95
Current Ratio (mrq)3.07
Book Value Per Share (mrq)1.26

Cash Flow Statement

Operating Cash Flow (ttm)-8.66M
Levered Free Cash Flow (ttm)-4.57M